A Single-Blind, Randomized, Placebo Controlled, Single Dose Safety, Tolerability and Pharmacokinetic Study of RBx 10017609 in Elderly Male and Female Subjects.
Phase of Trial: Phase I
Latest Information Update: 24 Aug 2016
At a glance
- Drugs RBx 10017609 (Primary)
- Indications Asthma; Chronic obstructive pulmonary disease
- Focus Adverse reactions
- 04 Jul 2012 Status changed from recruiting to completed as reported by Clinical Trials Registry - India.
- 22 Mar 2010 New trial record